Tempest Therapeutics Inc

1
NAS:TPST (USA)  
$ 3.54 +0.06 (+1.72%) 10:08 PM EST
At Loss
P/B:
2.93
Market Cap:
$ 78.65M
Enterprise V:
$ 58.75M
Volume:
401.13K
Avg Vol (2M):
1.13M
Also Trade In:
Volume:
401.13K
At Loss
Avg Vol (2M):
1.13M

Business Description

Description
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Name Current Vs Industry Vs History
Cash-To-Debt 1.9
Equity-to-Asset 0.52
Debt-to-Equity 0.77
Debt-to-EBITDA -0.75
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 14.2
3-Year EPS without NRI Growth Rate 12.9
3-Year FCF Growth Rate 14.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 60.81
9-Day RSI 49.4
14-Day RSI 47.75
6-1 Month Momentum % -12.71
12-1 Month Momentum % 106.11

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.29
Quick Ratio 4.29
Cash Ratio 4.17

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -49.2
Shareholder Yield % -49.5